Publication: BEHOLD-2: A phase I/II randomised study evaluating GSK5733584, a B7-H4-targeted antibody-drug conjugate, in combination with anti-cancer agents in patients with advanced solid tumours
Program
KU-Authors
KU Authors
Co-Authors
Yamamoto, N.
Kitano, S.
Ariyoshi, K.
Lheureux, S.
Zeng, X.
Cinat, G.
Kowalyszyn, R. D.
Bares, J. P.
Fernandez, O. C.
Veliz, I. F.
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
eng
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
Elsevier
Subject
Health sciences, Medicine, Oncology
Citation
Has Part
Source
Annals of Oncology
Book Series Title
Edition
DOI
10.1016/j.annonc.2025.10.1101
item.page.datauri
Link
Rights
N/A
Copyrights Note
Creative Commons license
Except where otherwised noted, this item's license is described as N/A